{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:10:48Z","timestamp":1792447848344,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Trisomy 21, characterized by the presence of an additional chromosome 21, leads to a set of clinical features commonly referred to as Down syndrome (DS). The pathological phenotypes observed in DS are caused by a combination of factors, such as mitochondrial dysfunction, neuroinflammation, oxidative stress, disrupted metabolic patterns, and changes in protein homeostasis and signal transduction, and these factors collectively induce neurological alterations. In DS, the triplication of chromosome 21 and the micronuclei arising from the missegregation of chromosomes are closely associated with inflammation and the development of redox imbalance. Autophagy, an essential biological process that affects cellular homeostasis, is a powerful tool to facilitate the degradation of redundant or dysfunctional cytoplasmic components, thereby enabling the recycling of their constituents. Targeting the autophagy process has been suggested as a promising method to balance intracellular inflammation and oxidative stress and improve mitochondrial dysfunction. In this review, we summarize the role of autophagy in regulating inflammation and redox homeostasis in DS and discuss their crosslinks. A comprehensive elucidation of the roles of autophagy in DS offers novel insights for the development of therapeutic strategies aimed at aneuploidy-associated diseases.<\/jats:p>","DOI":"10.3389\/fphar.2024.1491563","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:44:42Z","timestamp":1727844282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome"],"prefix":"10.3389","volume":"15","author":[{"given":"Xuehai","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoulong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B2","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2017.07.009","article-title":"Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism","volume":"114","author":"Barone","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"Mtor hyperactivation in down syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy","volume":"10","author":"Bordi","year":"2019","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.gene.2019.04.040","article-title":"An update on the interactions between alzheimer\u2019s disease, autophagy and inflammation","volume":"705","author":"Bostanciklioglu","year":"2019","journal-title":"Gene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in down\u2019s syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"108470","DOI":"10.1016\/j.fsi.2022.108470","article-title":"Polyethylene microplastics trigger cell apoptosis and inflammation via inducing oxidative stress and activation of the Nlrp3 inflammasome in carp gills","volume":"132","author":"Cao","year":"2023","journal-title":"Fish. Shellfish Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/alz.12185","article-title":"Targeting increased levels of APP in Down syndrome: posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model","volume":"17","author":"Chen","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B10","first-page":"1281","article-title":"Cu\/Zn-Superoxide dismutase and glutathione peroxidase during aging","volume":"35","author":"de Haan","year":"1995","journal-title":"Biochem. Mol. Biol. Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 overexpression in down syndrome correlates with the alteration of the Ho-1\/Bvr-a system: insights for transition to alzheimer\u2019s disease","volume":"44","author":"Di Domenico","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/epi-2016-0138","article-title":"Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from down syndrome and mouse models","volume":"9","author":"Do","year":"2017","journal-title":"Epigenomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-7091-6262-0_14","article-title":"Expression of apoptosis related proteins: RAIDD, ZIP kinase, Bim\/BOD, p21, Bax, Bcl-2 and NF-kappaB in brains of patients with Down syndrome","author":"Engidawork","year":"2001","journal-title":"J. Neural Transm. Suppl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","article-title":"Down syndrome and covid-19: a perfect storm?","volume":"1","author":"Espinosa","year":"2020","journal-title":"Cell Rep. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mito.2022.11.003","article-title":"Therapeutics for mitochondrial dysfunction-linked diseases in down syndrome","volume":"68","author":"Ganguly","year":"2023","journal-title":"Mitochondrion"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.18632\/aging.102677","article-title":"Down syndrome and alzheimer\u2019s disease: common molecular traits beyond the amyloid precursor protein","volume":"12","author":"Gomez","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via sting trafficking is a primordial function of the cgas pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","article-title":"Autophagy controls il-1beta secretion by targeting pro-il-1beta for degradation","volume":"286","author":"Harris","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fped.2020.00073","article-title":"Immune dysregulation in children with down syndrome","volume":"8","author":"Huggard","year":"2020","journal-title":"Front. Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/NEN.0000000000000083","article-title":"Mtor hyperactivation in down syndrome Hippocampus appears early during development","volume":"73","author":"Iyer","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","article-title":"P62 links autophagy and Nrf2 signaling","volume":"88","author":"Jiang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41418-018-0165-9","article-title":"Mitochondrial ROS-derived pten oxidation activates PI3K pathway for mTOR-induced myogenic autophagy","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Death Differ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s42003-021-02278-9","article-title":"Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway","volume":"4","author":"Krivega","year":"2021","journal-title":"Commun. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/ncomms7670","article-title":"Regulation of autophagy and the ubiquitin-proteasome system by the foxo transcriptional network during muscle atrophy","volume":"6","author":"Milan","year":"2015","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in human diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.03.006","article-title":"Cape and its synthetic derivative Vp961 restore BACH1\/Nrf2 axis in down syndrome","volume":"183","author":"Pagnotta","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s11357-024-01146-8","article-title":"Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine \u03b2-synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy","volume":"46","author":"Panagaki","year":"2024","journal-title":"Geroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ridd.2015.07.010","article-title":"Persistence of the benefit of an antioxidant therapy in children and teenagers with down syndrome","author":"Parisotto","year":"2015","journal-title":"Res. Dev. Disabil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"Mtor signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-3-7091-6380-1_20","article-title":"The \u201cgene dosage effect\u201d hypothesis versus the \u201camplified developmental instability\u201d hypothesis in Down syndrome","volume":"57","author":"Pritchard","year":"1999","journal-title":"J. Neural Transm. Suppl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"B37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12613","article-title":"Autophagy limits activation of the inflammasomes","volume":"281","author":"Takahama","year":"2018","journal-title":"Immunol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","article-title":"Mitochondrial dysfunction in Down syndrome: from pathology to therapy","volume":"511","author":"Tan","year":"2023","journal-title":"Neuroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/biof.184","article-title":"Mitochondrial dysfunction and Down\u2019s syndrome: is there a role for coenzyme Q (10)","volume":"37","author":"Tiano","year":"2011","journal-title":"Biofactors"},{"key":"B40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/ars.2016.6686","article-title":"Polyubiquitinylation profile in down syndrome brain before and after the development of alzheimer neuropathology","volume":"26","author":"Tramutola","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1523\/JNEUROSCI.0011-11.2011","article-title":"An increase in basal BDNF provokes hyperactivation of the AKT-mammalian target of rapamycin pathway and deregulation of local dendritic translation in a mouse model of down\u2019s syndrome","volume":"31","author":"Troca-Marin","year":"2011","journal-title":"J. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.molmed.2016.06.001","article-title":"Autophagy and immune senescence","volume":"22","author":"Zhang","year":"2016","journal-title":"Trends Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1352479","DOI":"10.3389\/fimmu.2024.1352479","article-title":"The cGAS-STING pathway in viral infections: a promising link between inflammation, oxidative stress and autophagy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-2012-120073","article-title":"Oxidative stress and memory decline in adults with down syndrome: longitudinal study","volume":"31","author":"Zis","year":"2012","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1491563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:44:44Z","timestamp":1727844284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1491563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":46,"alternative-id":["10.3389\/fphar.2024.1491563"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1491563","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"article-number":"1491563"}}